Natco Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Natco Pharma Quarterly Results    (NTPH)

Here are the latest quarterly results of Natco Pharma. For more details, see the Natco Pharma financial fact sheet and Natco Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Natco Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m5,4355,5674,5574,9234,8574,8224,5485,634 
Other income Rs m400233310210332308224187 
Turnover Rs m5,8355,8004,8675,1335,1895,1304,7725,821 
Expenses Rs m3,2303,4833,0743,0103,5143,5353,2653,923 
Gross profit Rs m2,2052,0841,4831,9131,3431,2871,2831,711 
Depreciation Rs m202207217220219254305280 
Interest Rs m5063526562533537 
Profit before tax Rs m2,3532,0471,5241,8381,3941,2881,1671,581 
Tax Rs m537454320410217244235360 
Profit after tax Rs m1,8161,5931,2041,4281,1771,0449321,221 
Gross profit margin %40.637.432.538.927.726.728.230.4 
Effective tax rate %22.822.221.022.315.618.920.122.8 
Net profit margin %33.428.626.429.024.221.720.521.7 
Diluted EPS Rs 10.9 9.6 7.2 8.6 7.1 6.3 5.6 7.3  
Diluted EPS (TTM) Rs 53.0 49.5 38.7 36.4 32.5 29.2 27.6 26.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Natco Pharma 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ALEMBIC  WOCKHARDT  PROCTER & GAMBLE HEALTH  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare NATCO PHARMA With:   ALEMBIC  WOCKHARDT  PROCTER & GAMBLE HEALTH  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare NATCO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Maruti Suzuki Rallies 7.5%(Closing)

After opening the day at record high levels, Indian share markets erased gains as the session progressed and ended on a flat note, led by a decline in IT stocks and index heavyweight HDFC Bank.

Views on news

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Dec 3, 2020 03:36 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NATCO PHARMA

NATCO PHARMA - MYLAN COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS